GlycoMimetics, Inc.

ACTIVE

9708 Medical Center Dr, 马里兰州蒙哥马利县, 马里兰州, United Stateswww.glycomimetics.comPublic51–100 employeesEstablished: 2003-01-01$11.6M

Also known as:

glycomimetics incorporated

Clinical Trials

7 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

2003

Overview

Trial Phase Distribution

Phase

Trials

Phase 1

81.5%

Phase 3

14.8%

Phase 2

3.7%

Trial Status Distribution

Active, not recruiting

25.9%

Completed

55.6%

Recruiting

3.7%

Terminated

14.8%

Clinical Trials

Trials sponsored by this organization (27)

A clinical study to determine the efficacy of Uproleselan when given in addition to anti-cancer drugs in adults with a type of cancer called acute myeloid leukemia

Phase 1

Active, not recruiting

May 2020380 participants

A clinical study to determine the efficacy of Uproleselan when given in addition to anti-cancer drugs in adults with a type of cancer called acute myeloid leukemia

Phase 1

Active, not recruiting

Feb 2020380 participants

A Study to Determine Safety and Tolerability of GMI-1359 in Subjects With HR+ Metastatic Breast Cancer

Phase 1

Terminated

interventional

Nov 20194 participants

A clinical study to determine the efficacy of Uproleselan when given in addition to anti-cancer drugs in adults with a type of cancer called acute myeloid leukemia

Phase 1

Active, not recruiting

Oct 2019380 participants

A clinical study to determine the efficacy of Uproleselan when given in addition to anti-cancer drugs in adults with a type of cancer called acute myeloid leukemia

Phase 1

Active, not recruiting

Jun 2019380 participants

A clinical study to determine the efficacy of Uproleselan when given inaddition to anti-cancer drugs in adults with a type of cancer called acutemyeloid leukemia

Phase 1

Active, not recruiting

Feb 2019380 participants

Study to Determine the Efficacy of Uproleselan (GMI-1271) in Combination With Chemotherapy to Treat Relapsed/Refractory Acute Myeloid Leukemia

Phase 3

Terminated

interventional

Oct 2018388 participants

A clinical study to determine the efficacy of Uproleselan when given inaddition to anti-cancer drugs in adults with a type of cancer called acutemyeloid leukemia

Phase 1

Active, not recruiting

Oct 2018380 participants

Page 1 of 4

Approvals

No approval data available

News

No news articles found

Back to Organizations